In a finding that may have implications for percutaneous left atrial appendage (LAA) occlusion devices, a single-center series suggests that removing or closing off the LAA during cardiac surgery for ...

Atrial fibrillation (AF) is the irregular and rapid beating of the atria. Patients with AF may be asymptomatic or may have symptoms such as fatigue, palpitations and chest pain. They also have an ...

High-quality evidence is lacking to support either surgical or percutaneous exclusion of the left atrial appendage (LAA) to reduce the risk of stroke in patients with nonvalvular A-fib, a new ...

PHILADELPHIA, PA — A new review highlights a significant number of adverse events with the off-label use of the Lariat (SentreHEART) snare device for the exclusion of left atrial appendage (LAA) in ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--SentreHEART, Inc., announced it has successfully completed nine First-In-Human procedures utilizing the LARIAT® with EpiRAIL™ at John Paul II hospital in Krakow, ...

Thoracoscopic exclusion of the left atrial appendage (with or without other cardiac surgery) in atrial fibrillation for the prevention of thromboembolism Closing the left atrial appendage of the heart ...

Atrial fibrillation (AF) is a major risk factor for disabling ischemic strokes. Anticoagulation is highly effective for stroke prevention in patients with AF, but a substantial number of patients are ...

Please provide your email address to receive an email when new articles are posted on . Medtronic announced the launch of its LAA exclusion system in the U.S. after its August 2023 FDA clearance. The ...

AtriCure, Inc. ATRC recently announced receipt of regulatory approval from China’s National Medical Products Administration (NMPA) for its AtriClip Left Atrial Appendage (LAA) Exclusion System. This ...

The left atrial appendage (LAA), a site of predilection for thrombus formation, is the primary source of thromboemboli in patients with nonvalvular atrial fibrillation (NVAF) who have a stroke ...